These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10468948

  • 1. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism.
    Wichers M, Springer W, Bidlingmaier F, Klingmüller D.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):759-65. PubMed ID: 10468948
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M, Wiese A, Schürmeyer TH, Brabant G.
    Exp Clin Endocrinol; 1993 Jun; 101(2):106-11. PubMed ID: 8405139
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [Abstract] [Full Text] [Related]

  • 7. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP.
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [Abstract] [Full Text] [Related]

  • 8. An assessment of optimal hydrocortisone replacement therapy.
    Howlett TA.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):263-8. PubMed ID: 9156032
    [Abstract] [Full Text] [Related]

  • 9. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
    Werumeus Buning J, Konopka KH, Brummelman P, Koerts J, Dullaart RPF, van den Berg G, van der Klauw MM, Tucha O, Wolffenbuttel BHR, van Beek AP.
    PLoS One; 2017 Mar; 12(7):e0180326. PubMed ID: 28686664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Tormey W, Smith D, Thompson CJ, McKenna MJ, Agha A.
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM, Freaney R, Smith TP, McBrinn Y, Murray B, McKenna TJ.
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
    Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A, Sanmarti A.
    J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
    [Abstract] [Full Text] [Related]

  • 18. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A.
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [Abstract] [Full Text] [Related]

  • 19. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
    Harbeck B, Danneberg S, Rahvar AH, Haas CS, Lehnert H, Kropp P, Mönig H.
    Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
    [Abstract] [Full Text] [Related]

  • 20. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B, Kropp P, Mönig H.
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.